ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,142.15
-0.06%
Dow Jones
38,778.10
0.49%
Gold vs US Dollar
2,323.19
0.12%
Brent Oil
83.67
-0.27%
Bitcoin
65,397.69
-1.64%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Quest Diagnostics Inc (DGX)

  7. Quest Diagnostics Inc (DGX) News

Quest Diagnostics (DGX)

Quest Diagnostics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:DGX
DateTimeSourceHeadlineSymbolCompany
11/06/202412:57PR Newswire (US)Quest Diagnostics Completes Acquisition of Select PathAI Diagnostics' Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer DiagnosisNYSE:DGXQuest Diagnostics Inc
31/05/202421:08PR Newswire (US)Blood-based MRD Test for Cancer Recurrence Can Generate Cost Savings in Colorectal Cancer Treatment, Finds Study in JAMA Health ForumNYSE:DGXQuest Diagnostics Inc
21/05/202421:29Edgar (US Regulatory)Form 8-K - Current reportNYSE:DGXQuest Diagnostics Inc
21/05/202414:19Edgar (US Regulatory)Form 8-K - Current reportNYSE:DGXQuest Diagnostics Inc
21/05/202400:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
21/05/202400:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
21/05/202400:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
21/05/202400:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
21/05/202400:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
21/05/202400:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
21/05/202400:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
21/05/202400:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
21/05/202400:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
21/05/202400:11Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
16/05/202421:15PR Newswire (US)Quest Diagnostics Elects Robert B. Carter, CIO of FedEx Corporation, to Board of DirectorsNYSE:DGXQuest Diagnostics Inc
15/05/202422:45PR Newswire (US)Quest Diagnostics Declares Quarterly Cash DividendNYSE:DGXQuest Diagnostics Inc
15/05/202413:43PR Newswire (US)Workforce Drug Test Cheating Surged in 2023, Finds Quest Diagnostics Drug Testing Index Analysis of Nearly 10 Million Drug TestsNYSE:DGXQuest Diagnostics Inc
07/05/202421:50PR Newswire (US)Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads ConferenceNYSE:DGXQuest Diagnostics Inc
06/05/202414:40PR Newswire (US)Quest Diagnostics Names Murali Balakumar Senior Vice President and Chief Information and Digital OfficerNYSE:DGXQuest Diagnostics Inc
01/05/202411:57PR Newswire (US)Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAINYSE:DGXQuest Diagnostics Inc
23/04/202411:45PR Newswire (US)Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024NYSE:DGXQuest Diagnostics Inc
22/04/202412:53PR Newswire (US)Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's DiseaseNYSE:DGXQuest Diagnostics Inc
02/04/202412:57PR Newswire (US)Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental DelayNYSE:DGXQuest Diagnostics Inc
26/03/202411:09PR Newswire (US)Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's DiseaseNYSE:DGXQuest Diagnostics Inc
19/03/202419:06PR Newswire (US)Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024NYSE:DGXQuest Diagnostics Inc
01/03/202421:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
01/03/202421:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
01/03/202421:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
01/03/202421:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
01/03/202421:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
 Showing the most relevant articles for your search:NYSE:DGX

Your Recent History

NASDAQ
CELUW
Celularity
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved